Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from CSL

Trump has flagged 200% tariffs on Australian pharmaceuticals. What do we produce here, and what’s at risk?

US President Donald Trump’s proposed tariffs on Australia’s pharmaceutical exports to the United States has raised alarm among industry and government leaders.

The Conversation

Labor offers $1bn in loans to Australian export companies and seeks to loosen US trade ties after Trump tariffs

Federal government unveils protective measures to help export-focused companies tap alternative markets

The Guardian - AU

US Pharma Lobby Targets Australia's AU$18B PBS, Urges Trump To Impose Punitive Tariffs

On March 11, a formal complaint was submitted to US Trade Representative Jamieson Greer, urging the Trump administration to take strong action against Australia's "damaging pricing policies."

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Drop in immunisation rates hits vaccine-maker's revenue

Sales of CSL's flu vaccines were down by double digits in the first half amid a fall in immunisation rates since the COVID-19 pandemic.

AAP

Eight years, three league titles and lots of money: how Oscar made a success of China stay

The Brazilian, in contrast to many other footballers, embraced living in China with his family and will be sorely missed

The Guardian - UK

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases

The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks.

Barchart

Moderna’s mRNA vaccines to be exempt from advisory committee scrutiny under $2bn Morrison-era deal

Exclusive: Critics say exemption ‘deeply concerning’ and risks creating separate assessment systems

The Guardian - AU

Read news from The Economist, FT, and more,
with one subscription

Caledonian Sleeper staff to start wearing body cams after 'increase in abuse'

CALEDONIAN Sleeper staff are set to wear body cameras amid concerns over an “increase in verbal abuse” ...

The National (Scotland)

Footballers who played in China

A look at some of the most high-profile foreign footballers who have had spells in the Chinese Super League...

FourFourTwo

Australian shares higher as gold hits record high

The ASX200 has finished higher, with losses for CSL and Seek and gains for Temple & Webster and goldminers.

AAP

CSL share price bleeds as operating expenses rise

CSL shares were on track for their worst performance in 10 months after the blood products giant reported higher-than-expected operating expenses.

AAP

3 Industrial Stocks With Upside Potential Based on Price Targets

The industrial sector is set for significant growth due to rising demand and the adoption of advanced technologies. Therefore, investing in strong industrial stocks Carlisle Companies (CSL), AerCap Holdings (AER), and Textron (TXT) with significant upside potential could be a smart move. Keep reading.

StockNews.com

3 Industrial Stocks With Strong Earnings Growth

The industrial sector is expected to witness considerable long-term growth, thanks to robust demand for industrial machinery and the adoption of advanced technologies. Against this backdrop, it could be wise to buy fundamentally strong industrial stocks Eaton Corporation (ETN), Trane Technologies (TT), and Carlisle Companies (CSL) with strong earnings growth.…

StockNews.com

A Chinese conglomerate loses control of its elite European soccer team, as Beijing fails to dominate the world's favorite sport

Oaktree took over Italian soccer club Inter Milan last week after owner Suning failed to pay back a $429 million loan.

Fortune

Get all your
news in one place.

100's of premium titles.
One news app.

Motor1

The 2025 BMW M4 CS Asks, 'What CSL?'

Cheaper and quicker than its limited-run brother, with a (nearly) identical ‘Ring time, the CS is the M4 track rat for the rest of us.

The Hindu

Cochin Shipyard organises safety conclave

Cochin Shipyard Limited (CSL) organised ‘Samsraya’, an event aimed at fortifying safety standards within the shipbuilding and ship repair sectors in India, on May 9 and 10.

The Hindu

The significance of carrier aviation | Explained

The Hindu explains the relevance of the INS Vikrant, India's indigenous aircraft carrier

AAP

Australian shares hit eight-day high, nudge record

The ASX200 has finished 0.3 per cent higher, closing fewer than 50 points away from its record high in March.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Cochin Shipyard signs ship repair agreement with U.S. Navy

Cochin Shipyard Limited partners with U.S. Navy for ship repair, expanding India's role as a regional hub.

StockNews.com

3 Industrial Stocks Positioned for Returns

The industrial sector shows promise, driven by robust domestic demand and marked advancements in efficiency and productivity. Within this vibrant landscape, fundamentally strong industrial stocks Carlisle Companies (CSL), Curtiss-Wright Corporation (CW), and Clearwater Paper (CLW) emerge as potential avenues for promising returns. Stay tuned for further insights.

The Hindu

Steel cut at Cochin Shipyard for zero emission feeder container vessel

Cochin Shipyard launches zero emission vessel project with Samskip, pioneering green hydrogen fuel technology for sustainable maritime transport.

AAP

Victoria seals deal worth up to $350m for old CSL site

The Victorian government has purchased the former CSL site in Melbourne's inner north and on-sold part of the land to an animal vaccine giant.

AAP

Aust close slightly lower, with more weakness from CSL

The local bourse has closed 0.15 per cent lower, with gains by the retail banks outweighed by losses from Macquarie, James Hardie, CSL and Seek.

AAP

'Vaccine fatigue' dampened CSL's first-half flu sales

CSL says new vaccines against shingles and the cold virus RSV have led to fewer people being immunised against the flu, but it still managed to grow sales.

AAP

CSL's potential heart attack drug a dud in huge trial

CSL shares have fallen after a blockbuster drug candidate that aimed to prevent secondary heart attacks failed in a major clinical trial.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.